Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cognitive health of Moscow residents 55 years and older: Epidemiological data].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Myoclonus in Alzheimer's disease].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Therapy prospects for post-stroke aphasia].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Results of the program to preserve cognitive skills and psycho-emotional health in Moscow Longevity Centers].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

Related Experiment Video

Updated: Jun 21, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

Depressive disorders in stroke patients.

E I Gusev1, A N Bogolepova

  • 1Department of Neurology and Neurosurgery, Russian State Medical University, Moscow, Russia.

Neuroscience and Behavioral Physiology
|July 22, 2009
PubMed
Summary
This summary is machine-generated.

Treatment with Opra significantly improved outcomes for patients suffering from post-stroke depression. This study found Opra to be an effective antidepressant and anxiolytic with minimal side effects.

More Related Videos

Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint
06:45

Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint

Published on: January 9, 2026

Related Experiment Videos

Last Updated: Jun 21, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint
06:45

Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint

Published on: January 9, 2026

Area of Science:

  • Neurology
  • Psychiatry
  • Pharmacology

Background:

  • Post-stroke depression (PSD) is a common and serious complication following ischemic stroke.
  • PSD negatively impacts patient quality of life, functional recovery, and overall prognosis.
  • Effective treatment options for PSD are crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of Opra in treating patients diagnosed with post-stroke depression.
  • To assess the antidepressant and anxiolytic effects of Opra in this patient population.
  • To determine the safety and side effect profile of Opra for PSD treatment.

Main Methods:

  • A study was conducted to assess the efficacy of Opra in patients with post-stroke depression.
  • Patient status improvements were monitored following treatment with Opra.
  • Adverse effects on daily living activities and cognitive functions were assessed.

Main Results:

  • Opra demonstrated significant efficacy, with 93.3% of patients showing improvements in their condition.
  • The treatment exhibited a notable anxiolytic effect in addition to its antidepressant properties.
  • Opra was found to have no adverse effects on daily living activities or cognitive functions, with minimal reported side effects.

Conclusions:

  • Opra is an effective treatment for post-stroke depression.
  • Opra offers both antidepressant and anxiolytic benefits with a favorable safety profile.
  • The findings suggest Opra can improve the quality of life and recovery for patients with PSD.